药效评价Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptor.
期刊:Molecular pharmacology发表年份:2013作者:Peter Keov; Celine Valant; Shane M Devine; J Robert Lane; Peter J Scammells; Patrick M Sexton; Arthur Christopoulos
